Acute Effects of Maximal Exercise on Balance and Cognitive Domains in Young Men
NCT07453043, Not applicable, Completed, University School of Physical Education, Krakow, Poland
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Acute Effects of Maximal Exercise on Balance and Cognitive Domains in Young Men | ClinicalTrials.gov |
| NCT number | NCT07453043 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 30 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University School of Physical Education, Krakow, Poland | ClinicalTrials.gov |
| Conditions | Basic Science | ClinicalTrials.gov |
| Interventions | maximal exercise | ClinicalTrials.gov |
| First posted | 2026-03-05 | ClinicalTrials.gov |
| Last updated | 2026-03-05 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Sensory analysis | Change from baseline to 20 minutes after intervention or after 20 minutes of passive rest | Sensory organization (sensory integration; multi-sensory organization) is the ability of an individual to effectively process individual sensory system input cues to maintain balance control. This is done by suppressing inaccurate sensory system inputs while selecting appropriately from other, more accurate sensory cues to generate appropriate motor and postural response strategies. The Sensory Organization Test, systematically assesses this ability, objectively isolating and quantifying the use of each sensory system and the adaptive (or maladaptive) responses of the central nervous system. It is calculated as a ratio of Equilibrium scores. The result is expressed as an inverse percentage between 0 and 100. | ClinicalTrials.gov |
| Primary | Balance Strategy | Change from baseline to 20 minutes after intervention or after 20 minutes of passive rest | The relative use of movement about the ankle, hips and upper body to maintain balance during the SOT is reflected in the strategy scores. Shear forces are exerted against the support surface whenever the body's COG accelerates in the horizontal direction. Sway movements about the ankle are confined to low frequencies (below 0.5 Hz), the resulting COG accelerations and shear are small. Hip movements are typically fast (1 Hz and above) and therefore, generate larger shear forces which are also higher in frequency. Strategy scores are calculated by comparing the peak-to-peak amplitude of the shear oscillation to the maximum possible shear of 25 pounds (11.4 kg). This comparison is expressed as a percentage, with scores near 100 indicating little, if any, shear (i.e. full ankle strategy), while scores approaching zero indicate maximum shear (i.e. full hip strategy). All data describing the displacement of the center of gravity were recorded on a stilometric platform. | ClinicalTrials.gov |
| Primary | Equilibrium scores | Change from baseline to 20 minutes after intervention or after 20 minutes of passive rest | The equilibrium score for each trial is calculated by comparing the angular difference between the patient's maximum anterior to posterior COG displacements to this theoretical maximum displacement. All data describing the displacement of the center of gravity were recorded on a stilometric platform. The result is expressed as an inverse percentage between 0 and 100. Scores approaching 0 indicate sway amplitudes approaching the limits of stability with a value of 100 indicating perfect stability. A score of 0 indicates that the patient "fell" on that trial. The SOT consists of six trials: 1. Test on a stationary platform with eyes open, 2. Test on a stationary platform with eyes closed, 3. Test on a stationary platform with eyes open, but moving surroundings, 4. Test on a moving platform, stationary surroundings, with eyes open, 5. Examination on a moving platform with eyes closed 6. Examination on a moving platform with eyes open a moving environment | ClinicalTrials.gov |
| Primary | Stroop Test | Change from baseline to 20 minutes after intervention or after 20 minutes of passive rest | Accuracy and reaction times were recorded for all trials. Reaction times (RTs) and response accuracy were calculated separately for congruent and incongruent trials. Accuracy was defined as the proportion of correct responses within each condition. RT analyses were restricted to correct trials only | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)